Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Shilstine 50 mg Injection
Manufacturer/Marketed By : Shilpa Medicare Ltd
$3.00 $0.90
Shilstine 50 mg Injection serves as a vital therapeutic agent designed to mitigate the harmful effects of certain chemotherapy drugs, particularly methotrexate, and effectively addresses cases of overdose from anticancer...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Calcium Leucovorin 50 mg
Active Pharmaceutical Ingredient
Shilstine 50 mg Injection
3.00$
0.90$
Shilstine 50 mg Injection serves as a vital therapeutic agent designed to mitigate the harmful effects of certain chemotherapy drugs, particularly methotrexate, and effectively addresses cases of overdose from anticancer treatments. This injectable formulation is particularly beneficial for patients suffering from megaloblastic anemia caused by folic acid deficiency when oral medications are not feasible. Additionally, Shilstine is often administered in conjunction with 5-fluorouracil to enhance treatment outcomes in advanced colorectal cancer. While it plays a crucial role in cancer therapy and supportive care, it is essential for patients to be aware of potential side effects and consult with healthcare professionals before use. Shilstine works by replenishing folate levels in the body, which is critical for DNA synthesis and repair, thereby supporting healthy cell function during rigorous cancer treatments. As a physician-recommended option, this injection underscores the importance of tailored cancer care, ensuring patients receive comprehensive support throughout their treatment journey. Always discuss your medical history and any ongoing medications with your healthcare provider to avoid complications.
Active Pharmaceutical Ingredient
Uses
• Shilstine 50 mg injection is primarily utilized as a rescue treatment following high-dose methotrexate therapy. This medication helps protect normal cells from the toxic effects associated with methotrexate, reducing the risk of long-term complications. By administering Shilstine 50 mg injection, healthcare providers can mitigate potential damage to vital organs such as the liver and kidneys. This protective measure is crucial for patients undergoing intensive chemotherapy.
• Another important use of Shilstine 50 mg injection is in the management of megaloblastic anemia. This condition occurs due to a deficiency of folic acid, leading to a reduced number of red blood cells. Patients often experience symptoms like fatigue, shortness of breath, and pale skin. By providing Shilstine 50 mg injection, clinicians can effectively address these symptoms and support the restoration of healthy red blood cell levels.
• Shilstine 50 mg injection plays a significant role in the treatment of colorectal cancer. This form of cancer affects the colon or rectum and requires effective therapeutic strategies for optimal management. Shilstine 50 mg injection is part of a comprehensive treatment plan that aims to improve patient outcomes. Its role in this context underscores the importance of targeted therapies in cancer care.
• In cases of folic acid antagonist overdose, Shilstine 50 mg injection is utilized to reduce toxicity and alleviate adverse effects. This application is critical for patients who may have ingested excessive amounts of folic acid antagonists. By administering Shilstine 50 mg injection, healthcare professionals can help counteract the negative impact of the overdose. This ensures that patients receive timely and effective care in emergency situations.
Benefits
Leucovorin Rescue Injection can reduce serious blood cell disorder symptoms like anemia, neutropenia, and thrombocytopenia, which occur as a side effect of some drugs like methotrexate, pyrimethamine, and trimethoprim. Calcium Leucovorin 50 mg Injection can help to decrease the side effects of chemotherapy drugs, such as nausea, vomiting, and diarrhea, by protecting normal cells from the toxic effects of chemotherapy. Shilstine 50 mg may help to increase the effectiveness of chemotherapy drugs by allowing them to work more effectively against cancer. Leucovorin Rescue Injection can help to improve the quality of life for cancer patients by reducing the side effects of chemotherapy and potentially increasing the effectiveness of cancer treatment.
Side Effects
Like all medications, Shilstine Prefilled Syringe can cause side effects, but they do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Urticaria
• Sleeplessness
• Uneasiness
• Fever
• Redness
• Abdominal pain
• Diarrhoea
• Vomiting
Common Side Effects
• Breathing difficulty
• Dizziness
• Severe allergic reaction
• Swelling all over the body
How To Use
Shilstine 50 mg Injection is given intravenously (IV) or intramuscularly (IM) and administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of Leucovorin Rescue Injection will depend on the clinical condition of the patient's age and medical history and other factors. It is important to follow your doctor's instructions carefully when using this medication.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Shilstine Prefilled Syringe. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Shilstine 50 mg Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Calcium Leucovorin 50 mg Injection should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Shilstine Injection. Shilstine 50 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Shilstine Prefilled Syringe, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Shilstine 50 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Calcium Leucovorin 50 mg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Calcium Leucovorin 50 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Shilstine 50 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Shilstine 50 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Shilstine 50 mg Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Shilstine 50 mg, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.